These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 34061378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
    Nevel KS, Pentsova E, Daras M.
    Leuk Lymphoma; 2019 Jul; 60(7):1677-1684. PubMed ID: 30648449
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
    Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, Abe M, Kinoshita T, Yoshino T, Iwatsuki K, Kagami Y, Tsuzuki T, Kurokawa M, Ito K, Kawa K, Oshimi K, NK-cell Tumor Study Group.
    Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Case report: Relapsed/refractory extranodal natural killer/T-cell lymphoma nasal type with extensive central nervous system involvement.
    Dapkevičiūtė-Purlienė A, Augustinavičius V, Žučenka A.
    Pathol Oncol Res; 2022 May; 28():1610866. PubMed ID: 36699620
    [Abstract] [Full Text] [Related]

  • 11. Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.
    Aaroe AE, Nevel KS.
    Curr Oncol Rep; 2019 Mar 27; 21(5):40. PubMed ID: 30919085
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas.
    Zing N, Fischer T, Federico M, Chiattone C, Ferreri AJM.
    Crit Rev Oncol Hematol; 2021 Nov 27; 167():103496. PubMed ID: 34653598
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours.
    Miyata-Takata T, Takata K, Kato S, Hu LM, Noujima-Harada M, Chuang SS, Sato Y, Maeda Y, Yoshino T.
    Histopathology; 2017 Aug 27; 71(2):287-295. PubMed ID: 28342197
    [Abstract] [Full Text] [Related]

  • 14. Treatment outcomes and prognostic analysis of elderly patients with extranodal natural killer/T-cell lymphoma, nasal type: a retrospective analysis.
    Wei L, Cong J, Yang L, Ye J, Li X, Yao N, Yang J, Cui X, Wu Y, Ding J, Wang J.
    Leuk Lymphoma; 2020 Dec 27; 61(12):2962-2968. PubMed ID: 32686544
    [Abstract] [Full Text] [Related]

  • 15. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 27; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 17. Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.
    Wei C, Cao X, Zhang W, Zhang Y, Wang W, Zhang L, Yang C, Feng J, Cai H, Chen M, Mao Y, Zhou D.
    Ann Hematol; 2020 Dec 18; 99(12):2801-2809. PubMed ID: 32399707
    [Abstract] [Full Text] [Related]

  • 18. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ, Hu LY, Geng QR, Chen J, Lu ZH, Rao HL, Liu Q, Jiang WQ, Huang HQ, Lin TY, Xia ZJ.
    Chin J Cancer; 2016 Sep 13; 35(1):87. PubMed ID: 27624700
    [Abstract] [Full Text] [Related]

  • 19. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature.
    Ely A, Evans J, Sundstrom JM, Malysz J, Specht CS, Wilkinson M.
    Orbit; 2012 Aug 13; 31(4):267-9. PubMed ID: 22681504
    [Abstract] [Full Text] [Related]

  • 20. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
    Alvarnas JC, Negrin RS, Horning SJ, Hu WW, Long GD, Schriber JR, Stockerl-Goldstein K, Tierney K, Wong R, Blume KG, Chao NJ.
    Biol Blood Marrow Transplant; 2000 Aug 13; 6(3A):352-8. PubMed ID: 10905773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.